Department of Women and Children's Health, School of Life Course and Population Sciences, King's College London, 10th Floor North Wing, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK.
Human Nutrition Laboratory, Institute of Food, Nutrition and Health, ETH Zurich, Zurich, Switzerland.
Eur J Clin Nutr. 2023 Jul;77(7):710-730. doi: 10.1038/s41430-022-01232-0. Epub 2022 Nov 9.
Pre-eclampsia can lead to maternal and neonatal complications and is a common cause of maternal mortality worldwide. This review has examined the effect of micronutrient supplementation interventions in women identified as having a greater risk of developing pre-eclampsia.
A systematic review was performed using the PRISMA guidelines. The electronic databases MEDLINE, EMBASE and the Cochrane Central Register of Controlled trials were searched for relevant literature and eligible studies identified according to a pre-specified criteria. A meta-analysis of randomised controlled trials (RCTs) was conducted to examine the effect of micronutrient supplementation on pre-eclampsia in high-risk women.
Twenty RCTs were identified and supplementation included vitamin C and E (n = 7), calcium (n = 5), vitamin D (n = 3), folic acid (n = 2), magnesium (n = 1) and multiple micronutrients (n = 2). Sample size and recruitment time point varied across studies and a variety of predictive factors were used to identify participants, with a previous history of pre-eclampsia being the most common. No studies utilised a validated prediction model. There was a reduction in pre-eclampsia with calcium (risk difference, -0.15 (-0.27, -0.03, I = 83.4%)), and vitamin D (risk difference, -0.09 (-0.17, -0.02, I = 0.0%)) supplementation.
Our findings show a lower rate of pre-eclampsia with calcium and vitamin D, however, conclusions were limited by small sample sizes, methodological variability and heterogeneity between studies. Further higher quality, large-scale RCTs of calcium and vitamin D are warranted. Exploration of interventions at different time points before and during pregnancy as well as those which utilise prediction modelling methodology, would provide greater insight into the efficacy of micronutrient supplementation intervention in the prevention of pre-eclampsia in high-risk women.
子痫前期可导致母婴并发症,是全球范围内导致产妇死亡的常见原因。本综述评估了针对子痫前期高危人群的微量营养素补充干预对该疾病的影响。
本研究采用 PRISMA 指南进行系统评价。检索了 MEDLINE、EMBASE 和 Cochrane 对照试验中心注册库中的相关文献,根据预先设定的标准确定符合条件的研究。对随机对照试验(RCT)进行荟萃分析,以评估高危人群中微量营养素补充对子痫前期的影响。
共确定了 20 项 RCT,补充剂包括维生素 C 和 E(n=7)、钙(n=5)、维生素 D(n=3)、叶酸(n=2)、镁(n=1)和多种微量营养素(n=2)。研究的样本量和招募时间点各不相同,研究采用了多种预测因素来识别参与者,其中以前有子痫前期病史最为常见。没有研究使用经过验证的预测模型。钙(风险差异,-0.15 [-0.27,-0.03,I=83.4%])和维生素 D(风险差异,-0.09 [-0.17,-0.02,I=0.0%])补充可降低子痫前期的发生率。
本研究结果表明,钙和维生素 D 补充可降低子痫前期的发生率,但由于样本量小、方法学差异和研究间异质性,结论受到限制。需要开展更多高质量、大规模的 RCT 来评估钙和维生素 D 的效果。探索在妊娠前后不同时间点的干预措施以及使用预测模型方法,可以更深入地了解高危妇女中微量营养素补充干预预防子痫前期的疗效。